Toll-Like Receptor 4 Promotes α-Synuclein Clearance and Survival of Nigral Dopaminergic Neurons

Stefanova, Nadia, Fellner, Lisa, Reindl, Markus, Masliah, Eliezer, Poewe, Werner, Wenning, Gregor K.·2011·The American Journal of Pathology
DOI 10.1016/j.ajpath.2011.04.013

Cited by (272)

Items 201–272 of 272

  1. Limited effects of dysfunctional macroautophagy on the accumulation of extracellularly derived α-synuclein in oligodendroglia: implications for MSA pathogenesis
    Lisa Fellner, Edith Buchinger, Dominik Brück, Regina Irschick, Gregor Karl Wenning, Nadia Stefanova · 2018 · BMC Neuroscience
  2. Gut Microbiota in Autophagy Regulation: New Therapeutic Perspective in Neurodegeneration
    Sarmistha Mitra, Yeasmin Akter Munni, Raju Dash, Toma Sadhu, Largess Barua, Md. Ariful Islam, Dipannita Chowdhury, Debpriya Bhattacharjee, Kishor Mazumder, Il Soo Moon · 2023 · Life
  3. The Interaction Between Nutraceuticals and Gut Microbiota: a Novel Therapeutic Approach to Prevent and Treatment Parkinson’s Disease
    Liyan Yao, Yong Yang, Xiaowei Yang, Mohammad J. Rezaei · 2024 · Molecular Neurobiology
  4. Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights
    Tong Guo, Li Chen · 2022 · European Journal of Inflammation
  5. Synucleinopathies Take Their Toll: Are TLRs a Way to Go?
    Gabriella Margherita Mazzotta, Nadia Ceccato, Carmela Conte · 2023 · Cells
  6. TNFα inhibitors as targets for protective therapies in MSA: a viewpoint
    Alain Ndayisaba, K. A. Jellinger, Thomas Berger, Gregor Karl Wenning · 2019 · Journal of Neuroinflammation
  7. Translational therapies for multiple system atrophy: Bottlenecks and future directions
    Stefanova, Nadia · 2018 · Autonomic Neuroscience
  8. Glial phagocytosis for synapse and toxic proteins in neurodegenerative diseases
    Yeseong Choi, Won‐Suk Chung · 2025 · Molecular Neurodegeneration
  9. Aβ, tau, α-synuclein, huntingtin, TDP-43, PrP and AA are members of the innate immune system: a unifying hypothesis on the etiology of AD, PD, HD, ALS, CJD and RSA as innate immunity disorders
    CLAUDIU I. BANDEA · 2013 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells
    Ana Florencia Vega-Benedetti, Clara Porcedda, Tommaso Ercoli, Giuliana Fusco, Chiara Burgaletto, Rita Pillai, Francesca Palmas, Anna Flavia Cantone, Fabrizio Angius, Paolo Solla et al. · 2024 · Journal of Neurology
  11. Advancements in understanding substantia nigra hyperechogenicity via transcranial sonography in Parkinson’s disease and its clinical implications
    Yuan-yuan Zhang, Xuhong Jiang, Pei-pei Zhu, Wenyan Zhuo, Li-bin Liu · 2024 · Frontiers in Neurology
  12. Exploring the Significance of Microglial Phenotypes and Morphological Diversity in Neuroinflammation and Neurodegenerative Diseases: From Mechanisms to Potential Therapeutic Targets
    Mai M. Anwar, Leonor Pérez‐Martínez, Gustavo Pedraza‐Alva · 2024 · Immunological Investigations
  13. Sortilin acts as an endocytic receptor for α‐synuclein fibril
    Shun Ishiyama, Takafumi Hasegawa, Naoto Sugeno, Junpei Kobayashi, Shun Yoshida, Yasuo Miki, Koichi Wakabayashi, Mitsunori Fukuda, Yasushi Kawata, Takaaki Nakamura et al. · 2023 · The FASEB Journal
  14. Tissue-specific features of microglial innate immune responses
    Raissa Timmerman, Saskia Maria Burm, Jeffrey John Bajramovic · 2020 · Neurochemistry International
  15. Autoantibody profiles in Alzheimer´s, Parkinson´s, and dementia with Lewy bodies: altered IgG affinity and IgG/IgM/IgA responses to alpha-synuclein, amyloid-beta, and tau in disease-specific pathological patterns
    Luisa Harriet Knecht, Katrine Dalsbøl, Anja Hviid Simonsen, Falk Pilchner, Jean Alexander Ross, Kristian Winge, Lisette Salvesen, Sára Bech, Anne‐Mette Hejl, Annemette Løkkegaard et al. · 2024 · Journal of Neuroinflammation
  16. Toward disease modification in multiple system atrophy: Pitfalls, bottlenecks, and possible remedies
    Florian Krismer, Klaus Seppi, Nadia Stefanova, Gregor Karl Wenning · 2016 · Movement Disorders
  17. The role of triggering receptor expressed on myeloid cells 2 in Parkinson’s disease and other neurodegenerative disorders
    Hannah Schwarz, Sarah Bässler, Denise Balta, Eileen Socher, Friederike Zunke, Philipp Arnold · 2022 · Behavioural Brain Research
  18. The role of autophagy in synucleinopathy: clearance versus spread of α-synuclein
    Emily Birnbaum, Zhenyu Yue · 2025 · Autophagy Reports
  19. Autophagy and Cell Death in Alzheimer’s, Parkinson’s and Prion Diseases
    Samo Ribarič, Irina Milisav Ribarič · 2019 · IntechOpen eBooks
  20. Regulation of the phagocytic activity of astrocytes by neuroimmune mediators endogenous to the central nervous system
    Sijie Shirley Yang, Svetlana Simtchouk, Julien Gibon, Andis Klegeris · 2023 · PLoS ONE
  21. Prevention of multiple system atrophy using human bone marrow-derived mesenchymal stem cells by reducing polyamine and cholesterol-induced neural damages
    Kyung‐Ran Park, Chul Ju Hwang, Hyung‐Mun Yun, In Jun Yeo, Dong‐Young Choi, Pil‐Hoon Park, Hyungsook Kim, Jung Tae Lee, Young Suk Jung, Sang‐Bae Han et al. · 2020 · Stem Cell Research & Therapy
  22. Pro-Oxidative and Inflammatory Actions of Extracellular Hemoglobin and Heme: Molecular Events and Implications for Alzheimer's and Parkinson Disease
    Nicole Bon Campomayor, Hee Jin Kim, Mikyung Kim · 2025 · Biomolecules & Therapeutics
  23. Genetic and immunological regulation of gut Microbiota: The Roles of TLRs, CLRs, and key proteins in microbial homeostasis and disease
    Marylyn Ayoub, Yara Abi Chmouni, Norman Damaa, Alaa Eter, Hilmi Medawar, Hilda E. Ghadieh, Samer I. Bazzi, Ziad Abi Khattar, Sami T. Azar, Frédéric Harb · 2025 · Gene
  24. Disease mechanisms as subtypes: Lysosomal dysfunction in the endolysosomal Parkinson's disease subtype
    Adamantios Mamais, Rebecca L. Wallings, Emily M. Rocha · 2023 · Handbook of clinical neurology
  25. Glycolipids in Parkinson's disease: beyond neuronal function
    Fokion Spanos, Michela Deleidi · 2023 · FEBS Open Bio
  26. Pathogenesis of multiple system atrophy
    Takafumi Hasegawa, Akio Kikuchi, Atsushi Takeda · 2013 · Neurology and Clinical Neuroscience
  27. Lack of functional STING modulates immunity but does not protect dopaminergic neurons in the alpha-synuclein pre-formed fibrils Parkinson’s disease mouse model
    Ida Hyllen Klæstrup, Line Sinnathamby Reinert, Sara Almeida Ferreira, Johanne Lauritsen, Gitte U. Toft, Hjalte Gram, Poul Henning Jensen, Søren R. Paludan, Marina Romero‐Ramos · 2025 · npj Parkinson s Disease
  28. Microglial Dysfunction in Brain Aging and Neurodegeneration
    Julia Marschallinger, Kira Irving Mosher, Tony Wyss‐Coray · 2017 · Springer eBooks
  29. Toxic Alpha-Synuclein and the Opening of the Gate: Blood–Brain Barrier Damage and Stepwise Leukocyte Infiltration
    Piotr Wójcik, Carsten Culmsee, Agata Adamczyk · 2026 · Cellular and Molecular Neurobiology
  30. Role of non-neuronal cells in neurorepair: a focus on proteinopathy and neurodegeneration
    Santiago Rodríguez-Carreiro, Maria del Carmen Nogales, David Jiménez-Galán, Sara Carmona-Lorenzo, Alicia Caro-Martín, Elisa Navarro, Noemí Esteras · 2024 · Regenerative medicine reports .
  31. TLR4 in Neurodegenerative Diseases: Alzheimer’s and Parkinson’s Diseases
    Claudia Balducci, Gianluigi Forloni · 2020 · Progress in inflammation research
  32. RETRACTED ARTICLE: Role of TLR2 and TLR4 Signaling in Parkinson’s Disease: An Insight into Associated Therapeutic Potential
    Gagandeep Kaur, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Arun Kumar, Sandeep Arora, SIMONA GABRIELA BUNGAU · 2021 · Journal of Molecular Neuroscience · Retracted
  33. Quantitative systems pharmacology model of α‐synuclein pathology in Parkinson's disease‐like mouse for investigation of passive immunotherapy mechanisms
    Olga Ivanova, Tatiana Karelina · 2024 · CPT Pharmacometrics & Systems Pharmacology
  34. Effectiveness of mesenchymal stem cell-derived extracellular vesicles therapy for Parkinson’s disease: A systematic review of preclinical studies
    Xuesong Wang, Yue Wang, Yan Xu, Shan-Rong Zhang, Yang Zhang, Lulu Peng, Nan Wu, Junsong Ye · 2025 · World Journal of Stem Cells
  35. Toll-Like Receptors (TLRs) in Neurodegeneration: Integrative Approach to TLR Cascades in Alzheimer’s and Parkinson’s Diseases
    Juan Manuel Zolezzi, Sussy Bastias Candia, Nibaldo C. Inestrosa · 2019 · IntechOpen eBooks
  36. Recent Advances in Neurodegeneration
    Antonella Borreca · 2019 · IntechOpen eBooks
  37. α-Synuclein strains influence multiple system atrophy via central and peripheral mechanisms
    Teresa Torre-Muruzabal, Anke Van der Perren, Audrey Coens, Anna Barber Janer, Sara Camacho-Garcia, Nadia Stefanova, Ronald Melki, Veerle Baekelandt, Wouter Peelaerts · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Binding domains of α-synuclein receptors with monomeric/oligomeric α-synuclein: Implications for Parkinson’s disease
    Rosalie Elvira, Jia Sheng Guan, Yuguang Mu, Eng‐King Tan, Zhidong Zhou · 2025 · Biomedicine & Pharmacotherapy
  39. Differential microglial responses to structurally distinct alpha-synuclein polymorphs
    Katherine Chang, Jina Kim, Michiyo Iba, Jae Hyeon Park, Alexandria Beilina, Zulfeqhar Ali Syed, Valentina Baena, Liam Horan-Portelance, Mark Cookson, Sungyong You et al. · 2025 · Molecular Brain
  40. Targeting TLR4 in Parkinson's disease: mechanisms and therapeutic prospects
    Shuo Dong, Jiayin Lu, Lingfeng Wu, Siyi Wang, 宫玉波, Jinglin Hu, Yang Liu, Xinhua Chen · 2026 · International Immunopharmacology
  41. Alpha-synuclein and neuroinflammation in Parkinson's disease
    Tatiana Varanita, Luigi Bubacco · 2020 · Elsevier eBooks
  42. Animal Models
    Nadia Stefanova · 2013 · Springer eBooks
  43. Molecular Basis of Neurodegeneration: Lessons from Alzheimer’s and Parkinson’s Diseases
    Juan Manuel Zolezzi, Sussy Bastias Candia, Nibaldo C. Inestrosa · 2019 · IntechOpen eBooks
  44. Recent updates on immunotherapy in neurodegenerative diseases
    Jotiram Salunkhe, Rajesh Ramesh Ugale · 2024 · Brain Research
  45. Gut-brain axis modulation in remote rehabilitation of Parkinson’s disease: reconstructing the fecal metabolome and nigral network connectivity
    Yuting Jin, Huan Wang, Jinan Song · 2025 · Frontiers in Neurology
  46. Redirecting microglia phenotype via inhibition of NFAT1 ameliorates deficits in mouse model of synucleinopathies
    Michiyo Iba, Yeon‐Joo Lee, Somin Kwon, Liam Horan-Portelance, Katherine Chang, Minhyung Kim, Natalie Landeck, Robert A. Rissman, Seung Jae Lee, Sungyong You et al. · 2025 · Experimental & Molecular Medicine
  47. Neuroprotective role of bilirubin in Parkinson's disease
    Yifan Zhang, Hanwei Liu, Huaiwen Cao, Mingchen Deng, Zheng Han, Xinyu Wu, Qian Wan, Ruotong Wang, Yuanyuan Xu, Jingwei Lai et al. · 2026 · Frontiers in Aging Neuroscience
  48. α‐Synuclein aggregation landscape from phase separation to neurotoxic intermediates
    Silvia Ariño, Giuliana Fusco, Alfonso De Simone · 2026 · FEBS Letters
  49. Pharmacological mechanisms of fisetin in neurodegenerative disorders: regulation of neuroinflammatory, oxidative, and autophagic pathways
    Anish Singh, Lovedeep Singh, Diksha Dalal · 2026 · Naunyn-Schmiedeberg s Archives of Pharmacology
  50. Phagocytosis by brain macrophages in central nervous system diseases: Dual effects, cellular heterogeneity, and targeted therapeutic strategies
    Benyu Su, Weiwei Dong, Luoxuan Su, Jiayu Ye, Qingwei Yao, Mingyan Liu, Ji Wu, Ke Du · 2026 · Pharmacological Research
  51. Microglia activation as a therapeutic target in multiple system atrophy: the timing, the good and the bad
    2016 · Macrophage
  52. Changes in the Immune System in Parkinson’s Disease
    Marina Romero‐Ramos · 2017 · Springer eBooks
  53. Нейроиммунные механизмы нейродегенеративных заболеваний: роль цитокинов и толл-подобных рецепторов
    2018 · Сибирский вестник психиатрии и наркологии
  54. Microglial Dysfunction in Brain Aging and Neurodegeneration
    Julia Marschallinger, Kira Irving Mosher, Tony Wyss‐Coray · 2019 · Springer eBooks
  55. Immune response during idiopathic Parkinson's disease: From humans to animal models
    Sara Konstantin Nissen, Sara Almeida Ferreira, Ida Hyllen Klæstrup, Marina Romero‐Ramos · 2021 · International review of movement disorders
  56. Modelling Parkinson’s Disease Pre-Clinically: A Novel Virus-Fibril Inducible Mouse Model Exploring Disease Characteristics and Therapeutic Intervention via Metabotropic Glutamate Receptor 5 Negative Allosteric Modulation
    Samantha C. Bureau · 2022
  57. Design of reprogrammed neuronal transplantation and nanobiomaterial-based microglial therapeutic technologies for management of Parkinson's disease
    Neal K. Bennett · 2016
  58. Studying non–cell-autonomous neurodegeneration in Parkinson’s disease with induced pluripotent stem cells
    Tuuli-Maria Sonninen, L. M. Plotnikova, Nihay Laham-Karam, Gundars Goldsteins, Jari Koıstınaho, Šárka Lehtonen · 2021 · Elsevier eBooks
  59. Mikroglial Toll-benzeri Reseptörlerin Alzheimer ve Parkinson Hastalıklarındaki Rolü
    Dilara Nemutlu Samur, Gül Özbey · 2021 · Akdeniz Medical Journal
  60. Alpha-synuclein spreading mechanisms in Parkinson's disease: The role of membrane receptors
    Inês Caldeira Brás, Tiago F. Outeiro · 2021 · International review of movement disorders
  61. Toll-like receptors in spinal cord derived neural precursor cells: implications on spinal cord injury and cell transplantation
    Marina Sánchez-Petidier · 2022
  62. Changes in the Immune System in Parkinson’s Disease
    Marina Romero‐Ramos · 2019 · Springer eBooks
  63. Transcriptome-guided optimization of in vitro culture conditions to study microglia in health and disease
    Raissa Timmerman · 2022
  64. The integrated stress response, a novel mediator of pro-inflammatory microglia
    Erica Kane, Nichola A. Cruickshanks, Lin Zhao, Sean P. Cregan, Shawn Narain Whitehead · 2025 · Research Square
  65. Additional file 1 of Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity
    Emil Gregersen, Cristine Betzer, Kim, Woojin S., Gergő E. Kovács, Lasse Reimer, Glenda M. Halliday, Steffen Thiel, Jensen, Poul Henning · 2021 · Figshare
  66. Alpha-synuclein and microglia in Parkinson’s disease and multiple system atrophy: A comprehensive review
    Jamir Pitton Rissardo, Ana Letícia Fornari Caprara · 2026 · Brain Circulation
  67. Étude de la composante neuroinflammatoire dans les DFT/SLA
    Julie Smeyers · 2020 · theses.fr (ABES)
  68. Étude moléculaire de l'inflammation chronique dans la maladie de Parkinson
    Anne‐Claire Compagnion · 2019 · theses.fr (ABES)
  69. Towards the identification of targets and markers of Parkinson’s disease-associated neuroinflammation
    Cansu Yildirim-Balatan · 2021 · theses.fr (ABES)
  70. Rôles de FOXO3 dans la réponse cellulaire au stress et la neurodégénérescence au cours de la maladie Parkinson
    Baptiste Texier · 2024 · theses.fr (ABES)
  71. Oligodendroglia as Active Immunomodulators in Demyelinating Diseases
    Joohyun Park, So Yeong Cheon, Bhabotosh Barman, Fuzheng Guo · 2026 · Neuroscience Bulletin
  72. Brain macrophages in neurodegeneration
    Rachel J. Johnston, Nicole A. Pagán Torres, Yangchen Li, Claudia Z. Han · 2026 · Advances in immunology